Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal.
Novo Nordisk shares plunge 9% after Alzheimer’s drug trial fails to hit key target
Related Posts
Trump hails meeting with Putin as ‘productive’ after talks over Ukraine fail to reach a breakthrough
Following the Friday meeting Trump said, “There’s no deal until there’s a deal.”
Build an Autonomous Wet-Lab Protocol Planner and Validator Using Salesforce CodeGen for Agentic Experiment Design and Safety Optimization
In this tutorial, we build a Wet-Lab Protocol Planner & Validator that acts as an intelligent agent for experimental design…
Meet mmBERT: An Encoder-only Language Model Pretrained on 3T Tokens of Multilingual Text in over 1800 Languages and 2–4× Faster than Previous Models
Table of contents Why was a new multilingual encoder needed? Understanding the architecture of mmBERT What training data and phases…